Duloxetine Capsule, Delayed Release
Product Images NDC 70518-1244

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 70518-1244). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

7ad45dfa A630 4e5f 85c0 25dc9e8bfbb7 01

FDA Label Image

7ad45dfa A630 4e5f 85c0 25dc9e8bfbb7 02

This text appears to be a summary of a study evaluating the proportion of patients experiencing relapse over time when treated with either a placebo or duloxetine. The data presented includes the number of patients with relapse at specific time points and mentions the use of the Kaplan-Meier estimator method for analysis. The graph shows the time from randomization to relapse in days.*

FDA Label Image

7ad45dfa A630 4e5f 85c0 25dc9e8bfbb7 03

This is a graph showing the proportion of patients experiencing relapse over time for two treatments (Placebo and Duloxetine). The x-axis represents the time from randomization to relapse in days, while the y-axis shows the percentage of patients with relapse. The data is analyzed using the Kaplan-Meier estimator method.*

FDA Label Image

7ad45dfa A630 4e5f 85c0 25dc9e8bfbb7 04

This is data related to the percentage of patients who showed improvement while using different doses of duloxetine and a placebo. The text includes information about duloxetine at 60mg and 20mg doses, as well as the placebo. It also mentions the percent improvement in pain from baseline.*

FDA Label Image

7ad45dfa A630 4e5f 85c0 25dc9e8bfbb7 05

Percentage of Patients Improved by checking the Percent Improvement in Pain from Baseline for Duloxetine 60mg BID, Duloxetine 60mg QD, and Placebo.*

FDA Label Image

7ad45dfa A630 4e5f 85c0 25dc9e8bfbb7 06

This is a table showing the percentage of patients improved in terms of pain relief after taking Duloxetine 60 mg twice daily, Duloxetine 60 mg once daily, and a placebo. The table also includes different percentage thresholds of improvement ranging from >0 to 100.*

FDA Label Image

7ad45dfa A630 4e5f 85c0 25dc9e8bfbb7 07

This text provides data on the percentage of patients improved based on different treatment groups. The effectiveness of Duloxetine at 120 mg twice daily and 60 mg once daily is compared to a placebo. The chart also shows the percentage improvement in pain from the baseline.*

FDA Label Image

7ad45dfa A630 4e5f 85c0 25dc9e8bfbb7 08

FDA Label Image

7ad45dfa A630 4e5f 85c0 25dc9e8bfbb7 09

This document discusses the percentage of patients who showed improvement in pain levels while taking a placebo and duloxetine 60/120 mg daily. The graph displays the percent improvement in pain from the baseline.*

FDA Label Image

7ad45dfa A630 4e5f 85c0 25dc9e8bfbb7 10

This description indicates the percentage of patients who showed improvement when taking Duloxetine 60 mg once daily compared to a placebo. It provides a visual representation of the improvement in pain from baseline using a chart.*

FDA Label Image

7ad45dfa A630 4e5f 85c0 25dc9e8bfbb7 11

This is a report showing the percentage of patients improved with Duloxetine 60/120 mg once daily compared to a placebo. It includes a graph illustrating percent improvement in pain from baseline (BOCF). The data suggests a clear improvement with Duloxetine compared to placebo based on the percentages.*

FDA Label Image

Remedy_label (Remedy Label)

This is a description of Duloxetine 60 mg delayed-release capsules in a quantity of 60 capsules. It is a prescription medication with the NDC number 70518-1244-01. The manufacturer is Lupin Pharma located in Baltimore, MD. The medication should be stored between 20-25°C (58-77°F) with excursions permitted to 15-30°C (59-86°F). The instructions for use can be found in the package insert. It is important to keep this medication out of the reach of children.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.